Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK

Author： Nuijten M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.4, 1999-10, pp. : 379-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letrozole is an effective option in the treatment of early-stage or advanced breast cancer in postmenopausal women

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 1, 2005-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Letrozole: A Review of its Use in Postmenopausal Women with Advanced Breast Cancer

By Lamb H.M.   Adkins J.C.  

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 1125-1140

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective

By Karnon Jonathan  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 237-250

Adis International

Access to resources Recommend Favorite

Letrozole: A Review of its Use in the Treatment of Postmenopausal Women with Hormone-Responsive Early Breast Cancer

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1681-1705

Adis International

Access to resources Recommend Favorite

Fulvestrant – a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer

By Possinger Kurt  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2549-2558

Informa Healthcare

Access to resources Recommend Favorite